Known targets — ChEMBL curated mechanism
ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ATP4AATP4BAXLBTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CHRM2CHRM3CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4FLT3HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3KCNH2KMT2AMAP2K1MAP2K2MEN1MLNRMPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PLK4PPARGRENS1PR1SLC6A2SLC6A3SLC6A4SMOTYK2atpAatpBatpCatpDatpEatpFatpFHatpGpol
The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR4 known ✓ | Q13639 | 5/20 | 0.37 |
| ▸ | KCNH2 known ✓ | Q12809 | 2/20 | 0.37 |
| ▸ | CPT2 known ✓ | P23786 | 1/20 | 0.36 |
| ▸ | CCR5 known ✓ | P51681 | 2/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.37 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | CPT1A | P50416 | 1/20 | 0.36 |
| ▸ | KDM1A | O60341 | 1/20 | 0.36 |
| ▸ | LDHA | P00338 | 1/20 | 0.34 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Maleic Acid SCHEMBL7401474 | 1.00 | HTR4 (0.37) | HTR4CYP2C9CYP1A2ALOX15NFKB1 | |
| SCHEMBL7402582 | 0.96 | HTR4 (0.39) | HTR4CYP2C9CYP1A2ALOX15NFKB1 | |
| Fumaric Acid SCHEMBL8015995 | 0.90 | MAPT (0.39) | HTR4CYP2C9CYP1A2ALOX15NFKB1 | |
| Maleic Acid SCHEMBL8015989 | 0.90 | MAPT (0.39) | HTR4CYP2C9CYP1A2ALOX15NFKB1 | |
| Maleic Acid SCHEMBL8133481 | 0.89 | KDM1A (0.37) | HTR4CYP2C9CYP1A2ALOX15NFKB1 | |
| Fumaric Acid SCHEMBL8133485 | 0.89 | KDM1A (0.37) | HTR4CYP2C9CYP1A2ALOX15NFKB1 | |
| SCHEMBL1039396 | 0.87 | HTR4 (0.40) | HTR4CYP2C9CYP1A2ALOX15NFKB1 | |
| Maleic Acid SCHEMBL7398825 | 0.87 | SMN1; SMN2 (0.35) | HTR4CYP2C9CYP1A2ALOX15NFKB1 | |
| Fumaric Acid SCHEMBL7398829 | 0.87 | SMN1; SMN2 (0.35) | HTR4CYP2C9CYP1A2ALOX15NFKB1 | |
| SCHEMBL7402277 | 0.86 | MAPT (0.42) | HTR4CYP2C9CYP1A2ALOX15NFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5618827-A | TREATING GASTROINTESTINAL, URINARY, CARDIOVASCULAR, CENTRAL NERVOUS SYTEM DISORDERS | GLAXO GROUP LIMITED (GB) | 1997-04-08 | — | — | US | disclosed |
| EP-0640081-A1 | SUBSTITUTED PHENYLCARBAMATES AND PHENYLUREAS, THEIR PREPARATION AND THEIR USE AS 5-HT ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 1995-03-01 | — | — | EP | disclosed |
| WO-1993020071-A1 | SUBSTITUTED PHENYLCARBAMATES AND PHENYLUREAS, THEIR PREPARATION AND THEIR USE AS 5-HT ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 1993-10-14 | — | — | WO | disclosed |